The DOI matches its Crossref record.
Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design
Open accessAbstract
Improving the affinity of a high‐affinity protein–protein interaction is a challenging problem that has practical applications in the development of therapeutic biomolecules. We used a combination of structure‐based computational methods to optimize the binding affinity of an antibody fragment to the I‐domain of the integrin VLA1. Despite the already high affinity of the antibody (Kd ∼7 nM) and the moderate resolution (2.8 Å) of the starting crystal structure, the affinity was increased by an order of magnitude primarily through a decrease in the dissociation rate. We determined the crystal structure of a high‐affinity quadruple mutant complex at 2.2 Å. The structure shows that the design makes the predicted contacts. Structural evidence and mutagenesis experiments that probe a hydrogen bond network illustrate the importance of satisfying hydrogen bonding requirements while seeking higher‐affinity mutations. The large and diverse set of interface mutations allowed refinement of the mutant binding affinity prediction protocol and improvement of the single‐mutant success rate. Our results indicate that structure‐based computational design can be successfully applied to further improve the binding of high‐affinity antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
Jankauskaitė, J., Jiménez-García, B., Dapkūnas, J., Fernández-Recio, J., & Moal, I. H. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty635 · Cited by 389
Computational design of antibody-affinity improvement beyond in vivo maturation
Lippow, S. M., Wittrup, K. D., & Tidor, B. (2007) · Nature Biotechnology · doi:10.1038/nbt1336 · Cited by 342
Beard, H., Cholleti, A., Pearlman, D., Sherman, W., & Loving, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082849 · Cited by 273
Self-citationRosettaAntibodyDesign (RAbD): a general framework for computational antibody design
Adolf-Bryfogle, J., Kalyuzhniy, O., Kubitz, M., Weitzner, B. D., Hu, X., Adachi, Y., Schief, W. R., & Dunbrack, R. L. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006112 · Cited by 227
Metadata
- Authors
- Clark, L. A., Boriack‐Sjodin, P. A., Eldredge, J., Fitch, C., Friedman, B., Hanf, K. J. M., Jarpe, M., Liparoto, S. F., Li, Y., Lugovskoy, A., Miller, S., Rushe, M., Sherman, W., Simon, K., & Van Vlijmen, H.
- Venue
- Protein Science
- Publisher
- Wiley
- Published
- 2006-05
- Volume
- 15
- Issue
- 5
- Pages
- 949-960
- ISSN
- 0961-8368 (ISSN-L)
- 1469-896X
- OpenAlex
- W2166103775
- Cited by
- 173
- References
- 0
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design. https://app.cochat.ai/papers/10.1110/ps.052030506
- The paper
- Clark, L. A., Boriack‐Sjodin, P. A., Eldredge, J., Fitch, C., Friedman, B., Hanf, K. J. M., Jarpe, M., Liparoto, S. F., Li, Y., Lugovskoy, A., Miller, S., Rushe, M., Sherman, W., Simon, K., & Van Vlijmen, H. (2006). Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design. Protein Science. https://doi.org/10.1110/ps.052030506
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.